Task: Answer the multiple-choice question.
Question: Which compound exhibits a 5.001\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2)n(C)c1=O
b) Cc1nn(-c2ccccc2)c(Cl)c1/C=N\NC(=O)c1cncc(Br)c1
Answer: b. Cc1nn(-c2ccccc2)c(Cl)c1/C=N\NC(=O)c1cncc(Br)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(-c2ccccc2)c(Cl)c1/C=N\NC(=O)c1cncc(Br)c1
Cc1nn(-c2ccccc2)c(Cl)c1/C=N\NC(=O)c1cncc(Br)c1
5-bromo-N-[(Z)-(5-chloro-3-methyl-1-phenylpyrazol-4-yl)methylideneamino]pyridine-3-carboxamide